Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2018

May 4, 2018

31949_dirs_2018-05-04_bdfd84b1-bdb5-4527-a331-c170c98f493e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-05-02

Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-05-02 Ordinary Shares M 293840 Acquired 1055540 Direct
2018-05-03 Ordinary Shares F 28519 $27.886 Disposed 1027021 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-05-02 Restricted Stock Units $ M 293840 Disposed Ordinary Shares (881519) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 43000 Indirect
Ordinary Shares 625954 Indirect

Footnotes

F1: The acquisition of 293,840 ordinary shares resulted from the vesting of an equal number of restricted stock units ("RSUs") on May 2, 2018. The issuer will release one-fifth of the RSUs (58,768
RSUs) as of the date hereof, and will release the other four-fifths on four separate dates hereafter. Mr. Doyle has sold sufficient RSUs to cover the tax liability. After the 293,840 RSUs have been
released, one-half of the remaining RSUs is scheduled to vest on each of May 2, 2019 and May 2, 2020, subject to Mr. Doyle's continued employment through such dates, pursuant to his Restricted
Share Unit Award Notice with NovoCure Limited, dated as of May 2, 2017.

F2: Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of fully-vested restricted stock units ("RSUs") granted by the issuer to the reporting
person and reported on a Form 4 filed on May 4, 2017.

F3: Mr. Doyle is the Managing Director of WFD Ventures LLC, the sole member of WFD-GP II LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.

F4: RSU represents the right to receive, at settlement, one (1) ordinary share.